Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Oscar Health, Inc.OSCR · Entity 3582 | VP, Finance & Accounting | March 05, 2021 | March 05, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Oscar Health, Inc.
Report date March 05, 2021 · Filed March 05, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-03-05 transaction · row 1
1 source rowRow 1 · 2021-03-05 · Sale · Disposed 6,661 · Balance 0 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 17 |
Reported balance
After 2021-03-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-03-05 · Grant · Acquired 17 · Balance 17 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2: The restricted stock units vest upon the earlier of (i) 180 days after the IPO date, or (ii) the second day following the expiration of the underwriter-mandated lock-up period associated with the Issuer's initial public offering. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The restricted stock units vest upon the earlier of (i) 180 days after the IPO date, or (ii) the second day following the expiration of the underwriter-mandated lock-up period associated with the Issuer's initial public offering.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2021 Filed Mar 5, 2021 23:00 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantRestricted Stock Units · Derivative | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-010167 · doc4.xml · derivative · entry 2 Fischel Ari · CIK 0001844233 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Underlying: Class A Common Stock · 17 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) 180 days after the IPO date, or (ii) the second day following the expiration of the underwriter-mandated lock-up period associated with the Issuer's initial public offering. F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) 180 days after the IPO date, or (ii) the second day following the expiration of the underwriter-mandated lock-up period associated with the Issuer's initial public offering. Read SEC document |
| March 05, 2021 Filed Mar 5, 2021 23:00 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 6,661 | $39.00 | $259,779.00 |
DisclosureSEC source: 0000899243-21-010167 · doc4.xml · nonDerivative · entry 1 Fischel Ari · CIK 0001844233 · VP, Finance & Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.